Cart
sales@molnova.com
LY-301664
CAS No. 221176-49-4
LY-301664( LY 301664 | LY301664 )
Catalog No. M27113 CAS No. 221176-49-4
LY-301664 is a bio-active Olanzapine impurity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 448 | In Stock |
|
| 10MG | 642 | In Stock |
|
| 25MG | 981 | In Stock |
|
| 50MG | 1332 | In Stock |
|
| 100MG | 1782 | In Stock |
|
| 500MG | 3573 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameLY-301664
-
NoteResearch use only, not for human use.
-
Brief DescriptionLY-301664 is a bio-active Olanzapine impurity.
-
DescriptionLY-301664 is a bio-active Olanzapine impurity.
-
In Vitro——
-
In Vivo——
-
SynonymsLY 301664 | LY301664
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number221176-49-4
-
Formula Weight230.29
-
Molecular FormulaC12H10N2OS
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCc1cc2c(Nc3ccccc3NC2=O)s1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Bimpisidis Z, et al. Differential effects of gaseous versus injectable anesthetics on changes in regional cerebral blood flow and metabolism induced by l-DOPA in a rat model of Parkinson's disease. Exp Neurol. 2017 Jun;292:113-124.
molnova catalog
related products
-
FEN1 Inhibitor C2
FEN1-IN-4 is an inhibitor of human flap endonuclease-1 (hFEN1)FEN1 Inhibitor C2 inhibition selectively impairs proliferation of colon cancer cells deficient in Cdc4 and Mre11a, both frequently mutated in colorectal cancers.?
-
GS-6620 PM
GS-6620 PM is a derivative of GS-6620, an orally administered anti-hepatitis C virus polymerase inhibitor and a novel potent C-nucleoside adenine analogue monophosphate prodrug.
-
EN300-203561
EN300-203561
